CIK 0001137883
- Non-accelerated filer
- Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 207273918
- Phone
- +1 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-01-23 | ACCBT Corp. 10% owner | Exercise or conversion · Right to Acquire Warrant to Purchase Common Stock | −4,537,500 | 0 | ||
| 2011-01-23 | ACCBT Corp. 10% owner | Exercise or conversion · Right to Acquire Common Stock | −10,499,999 | 0 | ||
| 2010-12-16 | SHORR ROBERT G L Director | Grant or award | +200,000 | 300,000 | ||
| 2010-12-16 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2010-12-16 | TAUB MALCOLM S Director | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2010-12-16 | Israeli Avi Director | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2010-06-23 | Sossover Liat Chief Financial Officer | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2010-05-06 | TAUB MALCOLM S Director | Grant or award | +100,000 | 100,000 | ||
| 2010-04-13 | Israeli Avi Director | Grant or award · Stock Option (right to buy) | +166,666 | 166,666 | ||
| 2010-02-24 | ACCBT Corp. 10% owner | Exercise or conversion · Right to Acquire Common Stock | −2,000,001 | 10,499,999 | ||
| 2010-02-22 | STOLICK DAVID Chief Financial Officer | Sale | −100,000 | $0.36 | $36K | 150,000 |
| 2010-02-17 | STOLICK DAVID Chief Financial Officer | Sale | −2,000 | $0.36 | $720 | 250,000 |
| 2010-02-16 | STOLICK DAVID Chief Financial Officer | Sale | −3,000 | $0.36 | $1K | 392,000 |
| 2010-02-16 | STOLICK DAVID Chief Financial Officer | Sale | −140,000 | $0.36 | $50K | 252,000 |
| 2010-02-12 | STOLICK DAVID Chief Financial Officer | Sale | −5,000 | $0.36 | $2K | 395,000 |
| 2010-02-12 | STOLICK DAVID Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) | +400,000 | 0 | ||
| 2009-12-13 | ARBEL IRIT Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2009-10-28 | ACCBT Corp. 10% owner | Exercise or conversion · Right to Acquire Common Stock | −9,916,667 | 12,500,000 | ||
| 2009-10-26 | SHORR ROBERT G L Director | Sale | −40,000 | $0.31 | $12K | 100,000 |
| 2009-10-22 | SHORR ROBERT G L Director | Sale | −10,000 | $0.37 | $4K | 140,000 |
Page 16 of 22 · 426 trades